Modified FOLFIRINOX in Pancreatic Cancer Patients Age 75 or Older

BACKGROUND: Although FOLFIRINOX (5-Fluorouracil + leucovorin + irinotecan + oxaliplatin) is now the standard of care for patients (pts) with metastatic pancreatic cancer (PC) based on the 2011 study by Conroy et al. which demonstrated improved median overall survival (mOS), pts > 75 yrs old were...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Pancreatology
Hoofdauteurs: Mizrahi, Jonathan D., Rogers, Jane E., Hess, Kenneth R., Wolff, Robert A., Varadhachary, Gauri R., Javle, Milind M., Shroff, Rachna T., Ho, Linus, Fogelman, David R., Raghav, Kanwal P.S., Overman, Michael J., Pant, Shubham
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160008/
https://ncbi.nlm.nih.gov/pubmed/31932214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pan.2020.01.005
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items